The Challenges of Identifying Biomarkers of Psychiatric Illness
There is minimal overlap in neurologic variations among individuals with severe psychiatric conditions such as schizophrenia spectrum disorders and bipolar disorder.
PA YIR Schizophrenia 2018
Latent Structure of Negative Symptoms in Schizophrenia Best Conceptualized by 5-Domain Model
Existing 2-dimensional models are likely not sufficient to capture the complexity of negative symptoms in schizophrenia.
Remission of Schizophrenia Seen With Amisulpride, Clozapine
Remission can be achieved for most cases of schizophrenia and schizophreniform disorder with amisulpride and clozapine.
Dose-Response Relationship Observed Between CBT, Reduction in Schizophrenia Symptoms
The dose-response relationship observed between CBT and schizophrenia outcome may be salient to clinicians in titrating treatment strategies.
The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
One of the main reasons for the frequent misdiagnosis of catatonia is the continuing misconception that it is synonymous with schizophrenia.
Second Generation Long-Acting Injectable Drugs Effective for Schizophrenia
The findings support second generation long-acting injectable antipsychotic drug use as early treatment option to increase treatment adherence and to decrease the risk of relapse, hospitalization, and deteriorating social functions.
Validation of 5-Factor Brief Negative Symptom Scale in Schizophrenia
Investigators sought to validate the factorial structure of BNSS-related negative symptoms across a range of cultures and languages.
Distinct Characteristics in Children at Risk for Schizophrenia vs Bipolar Disorder
The findings of this study contribute to the understanding of the neurodevelopmental cognitive vulnerability in middle childhood for the children of people with either schizophrenia or bipolar disorder.
Holistic Sleep Experiences Crucial to Understanding Psychosis
While researchers continue learning about specific interactions between poor sleep and psychotic symptoms, clinicians should be incorporating more comprehensive questions about sleep into their assessment of patients.
Efficacy of MIN-101 in Treating Negative Symptoms of Schizophrenia
Researchers hope that in demonstrating the potential efficacy of MIN-101, they may improve the pharmacotherapy options available to patients with schizophrenia.
Next post in Schizophrenia and Psychoses
